MedPath

Safety and Efficacy of Different Onset Times of Treatment With Pulsed Dye Laser on Improvement of Surgical Scars

Not Applicable
Terminated
Conditions
Scar
Interventions
Procedure: pulsed dye laser therapy
Registration Number
NCT00506363
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

The appearance of skin after surgery plays an important role in patient's self confidence and life style. In fact, Keloids and hypertrophic scars are abnormal wound responses appearing in predisposed individuals after surgery. Among different kind of lasers, used to improve the appearance of hypertrophic scars and keloids, pulsed dye laser is now being used successfully in treatment of scars. Pulsed dye laser is effective in improving the color, height, texture, and elasticity of scars. Also, treatment with this technique is noninvasive, minimally uncomfortable, and requires no anesthesia. This study will assess the efficacy and safety of different onset times of treatment with pulsed dye laser on improvement of surgical scars.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Surgical scar with minimum length of 6 cm
Read More
Exclusion Criteria
  • History of light sensitivity or photodermatoses
  • History of adverse reactions to laser treatment
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Apulsed dye laser therapypulsed dye laser and dynamic cooling device on the day of suture removal
Bpulsed dye laser therapypulsed dye laser and dynamic cooling device 2 months after suture removal
Cpulsed dye laser therapydynamic cooling device
Primary Outcome Measures
NameTimeMethod
pigmentation, pliability, width and height of surgical scarsbaseline, middle of the study, 1 and 3 months after the last treatment session
Secondary Outcome Measures
NameTimeMethod
1- Clinical appearance of scar 2- Patient's satisfaction (scar erythema, scar thickness and scar induration) - Adverse events1 and 3 months after the last treatment session

Trial Locations

Locations (1)

Center for research and training in skin diseases and leprosy

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath